CN111733185A - Method for realizing improvement of animal meat quality through Mdfi gene editing and application - Google Patents
Method for realizing improvement of animal meat quality through Mdfi gene editing and application Download PDFInfo
- Publication number
- CN111733185A CN111733185A CN202010613570.3A CN202010613570A CN111733185A CN 111733185 A CN111733185 A CN 111733185A CN 202010613570 A CN202010613570 A CN 202010613570A CN 111733185 A CN111733185 A CN 111733185A
- Authority
- CN
- China
- Prior art keywords
- mdfi
- animal
- gene
- muscle
- myhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101100400779 Mus musculus Mdfi gene Proteins 0.000 title claims abstract description 97
- 241001465754 Metazoa Species 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 56
- 235000013372 meat Nutrition 0.000 title claims abstract description 47
- 238000010362 genome editing Methods 0.000 title claims abstract description 20
- 230000006872 improvement Effects 0.000 title claims abstract description 11
- 210000003205 muscle Anatomy 0.000 claims description 55
- 108091026890 Coding region Proteins 0.000 claims description 18
- 241000702421 Dependoparvovirus Species 0.000 claims description 14
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 239000013613 expression plasmid Substances 0.000 claims description 7
- 210000004291 uterus Anatomy 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- 238000007918 intramuscular administration Methods 0.000 claims description 2
- 230000002018 overexpression Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract 1
- 102000005604 Myosin Heavy Chains Human genes 0.000 description 64
- 108010084498 Myosin Heavy Chains Proteins 0.000 description 64
- 210000004027 cell Anatomy 0.000 description 38
- 241000282887 Suidae Species 0.000 description 32
- 108090000623 proteins and genes Proteins 0.000 description 29
- 102000004169 proteins and genes Human genes 0.000 description 24
- 210000001087 myotubule Anatomy 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 19
- 241000282898 Sus scrofa Species 0.000 description 15
- 239000008055 phosphate buffer solution Substances 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 13
- 210000003875 slow muscle fiber Anatomy 0.000 description 11
- 238000001262 western blot Methods 0.000 description 11
- 238000005406 washing Methods 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000010166 immunofluorescence Methods 0.000 description 8
- 210000003141 lower extremity Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 235000015277 pork Nutrition 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 6
- 210000002027 skeletal muscle Anatomy 0.000 description 6
- 238000011529 RT qPCR Methods 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 4
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102000036675 Myoglobin Human genes 0.000 description 4
- 108010062374 Myoglobin Proteins 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 210000003945 type 2b muscle cell Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000018832 Cytochromes Human genes 0.000 description 3
- 108010052832 Cytochromes Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000002414 glycolytic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229950010131 puromycin Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000003307 slaughter Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 2
- 101150017040 I gene Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010370 cell cloning Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 244000309715 mini pig Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000003098 myoblast Anatomy 0.000 description 2
- 230000004070 myogenic differentiation Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 239000008191 permeabilizing agent Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100024013 Golgi SNAP receptor complex member 2 Human genes 0.000 description 1
- 101710178610 Golgi SNAP receptor complex member 2 Proteins 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 108700001591 MyoD Proteins 0.000 description 1
- 102100033694 MyoD family inhibitor Human genes 0.000 description 1
- 101710120678 MyoD family inhibitor Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 101150029455 TNNI1 gene Proteins 0.000 description 1
- 101150077207 TNNI2 gene Proteins 0.000 description 1
- 101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003948 fast twitch a Anatomy 0.000 description 1
- 210000001512 fast-twitch muscle fiber Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000028742 placenta development Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000012488 skeletal system development Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000001189 slow twitch fiber Anatomy 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000003158 yeast two-hybrid assay Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a method for realizing animal meat quality improvement through Mdfi gene editing, which is realized through overexpression of an Mdfi gene. Therefore, the method has the following beneficial effects: 1. compared with the breeding angle, the method for improving the meat quality of animals from the gene editing angle is more controllable and has very obvious effect; 2. a method for improving meat quality of animals in terms of gene editing, the meat quality trait obtained by the method being heritable; 3. the method for improving the meat quality of animals from the aspect of gene editing is safe, controllable and environment-friendly.
Description
Technical Field
The invention relates to the technical field of biology, in particular to a method for improving animal meat quality through Mdfi gene editing and application.
Background
Skeletal muscle is an important component of the animal body, and about 45% is skeletal muscle. Pork accounts for more than 60% of meat consumption of residents in China, and is a main animal protein source for people. With the improvement of living standard, people have higher requirements on meat quality. The meat quality traits belong to typical multi-gene control economic traits, the forming mechanism of the meat quality traits is complex and is influenced by a plurality of factors such as variety, age, sex, nutrition, heredity and the like, and meanwhile, the meat quality traits are difficult to measure, slaughter determination is needed, and the determination cost is high, so the improvement of the meat quality traits is the difficult point and the key point of research of animal science workers at present. Skeletal muscle development is the process by which myoblasts proliferate and differentiate to form muscle fibers, and muscle proteins deposit. Vertebrate muscles are composed primarily of muscle fibers, which occupy 75% to 90% of the muscle tissue, and the morphological characteristics of muscle fibers determine the muscle properties. A large number of researches show that the composition of the muscle fiber type is closely related to important traits related to meat quality, such as meat color, tenderness (shearing force), pH value 24h after slaughter, drip loss and the like (Morales et al 2015; Wood et al 1999; Guojia 2011), so that the research and the improvement of the composition of the muscle fiber type have a direct guiding function on the improvement of the meat quality traits of pigs.
The myosin heavy chain (MyHC) subtypes in adult mammalian skeletal muscle fibers fall into 4 major classes: type I (MyHC I), type IIA (MyHC IIa), type IIx/d (MyHC IIx/d) and type IIB (MyHC IIb) (Schiaffeo et al, 1989). MyHC I corresponds to a slow-oxidizing muscle fiber, MyHC IIa to a fast-oxidizing muscle fiber, MyHC IIb to a fast-glycolytic muscle fiber, and MyHC IIx/d is between MyHC IIa and MyHC IIb, which are intermediate muscle fibers (Ashmore et al, 1972). Meat color is one of the important indicators that people use to evaluate meat quality organoleptically (O' Sullivan et al, 2003). Type I and IIA muscle fibers are found primarily in slow muscles (e.g. soleus), are highly oxidative, are rich in myoglobin (Mb) and cytochromes (cytochromes), and are bright red in muscle color (schiffinoet al, 2011). Type IIB muscle fibers are found primarily in the fast muscles (e.g., extensor digitorum longus and longissimus dorsi), have relatively low myoglobin and cytochrome contents, and are darker in muscle tone (Tseng et al, 2010). Research shows that different parts of the same pig have different types of skeletal muscle fibers, such as longissimus dorsi, biceps femoris, semimembranosus and other type IIB muscle fibers with higher content, while the psoas major contains higher type IIA muscle fibers and lower type IIB muscle fibers (Chang et al, 2003). The pH, intramuscular fat content, flesh color, etc. of the porcine psoas major and semitendinosus 24h after slaughter are positively correlated with the type I muscle fiber ratio (Shen et al, 2015). These studies all showed that the longissimus dorsi of pigs predominates in type IIB muscle fibers, while the psoas major muscle predominates in type I and IIA muscle fibers. In the study of the major psoas and the longissimus dorsi of the long white pigs, duroc pigs and baccharpy pigs, the meat color score of the major psoas with more oxidized fibers was found to be higher than that of the longissimus dorsi with a higher proportion of glycolytic fibers (Chang et al, 2003). In different pig species, the expression quantity of MyHC of different types is different, for example, the expression of MyHC I gene in the longissimus dorsi of the Bama miniature pigs which are 30 days and 60 days old at birth is obviously higher than that of Changbai pigs at the same age; the expression of MyHC I gene in the longissimus dorsi of 300-day-old Bama miniature pigs is significantly higher than that of 180-day-old Changbai pigs (Aokiazi, Guangxi university, 2014 Master paper). After birth, the number of muscle fibers has been determined, but the muscle fiber types remain highly plastic, controlled by multiple genes. The functional gene or genetic marker for controlling the quality of the livestock and poultry meat is excavated and can be used for genetic improvement of the quality of the livestock and poultry meat.
Mdfi (MyoD family inhibitor), also known as I-mf (inhibitor of MyoD family), was originally discovered by Chen et al (1996) in a mouse embryonic cDNA library by yeast two-hybrid assay to interact with a new gene of MyoD protein family. Subsequently researchers found that Mdfi also played an important role in mouse placental development (Kraut et al, 1998), skeletal development (oncogene al, 2013), disease, and tumorigenesis (Lin et al, 2015; Ma et al, 2018; Wu et al, 2015).
Disclosure of Invention
The invention aims to provide a method for improving the quality of animal meat by Mdfi gene editing so as to solve the problem of improving the quality of the animal meat.
According to one aspect of the invention, there is provided a method for achieving improved meat quality in an animal by Mdfi gene editing, the method comprising overexpressing the Mdfi gene. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
In certain embodiments, the method comprises injecting Mdfi in the animal muscle. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
In certain embodiments, the method comprises injecting an adeno-associated virus comprising an Mdfi coding region in the muscle of the animal. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
In certain embodiments, the method comprises injecting an adeno-associated virus comprising an Mdfi coding region in an animal muscle at a virus titer of 1012vg/mL, 10-15. mu.L per spot. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
In certain embodiments, the method comprises injecting an expression plasmid containing an Mdfi coding region in the muscle of the animal. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
In certain embodiments, the method comprises obtaining a transgenic animal that overexpresses the Mdfi gene. Thus, the meat quality of the transgenic animal obtained is improved and the properties are heritable.
In certain embodiments, the method comprises obtaining an animal that overexpresses the Mdfi gene by injecting the Mdfi gene into a fertilized egg and then transplanting into the uterus of a surrogate pregnant animal. Therefore, the meat quality of animals can be improved efficiently, and the method is safe, controllable and environment-friendly.
According to another aspect of the present invention, there is provided a use of the edited Mdfi gene for quality improvement of animal meat.
In certain embodiments, editing the Mdfi gene comprises overexpressing the Mdfi gene in the animal.
In certain embodiments, overexpressing the Mdfi gene comprises at least one of injecting an expression plasmid containing the Mdfi coding region in the muscle of an animal, injecting an adeno-associated virus containing the Mdfi coding region in the muscle of an animal, overexpressing a transgenic animal for the Mdfi gene, injecting the Mdfi gene into a fertilized egg, and transplanting the Mdfi gene into the uterus of a surrogate pregnant animal to obtain an animal overexpressing the Mdfi gene.
The invention has the beneficial effects that:
1. compared with the breeding method, the method for improving the meat quality of the animals from the gene editing perspective is more controllable and has very obvious effect.
2. A method for improving meat quality of animals in terms of gene editing, the meat quality shape obtained by the method is heritable.
3. The method for improving the meat quality of animals from the aspect of gene editing is safe, controllable and environment-friendly.
Drawings
FIG. 1 shows the results of Westernblot detection of Mdfi and myofiber type MyHC-tagged proteins in muscle tissues of Laiwu pigs and big white pigs: FIG. A is the protein levels of the lumbar major muscle tests Mdfi, MyHC I, MyHC IIa and MyHC IIb of the Laiwu pigs and the large white pigs, and FIG. B is the protein levels of the lumbar major muscle tests Mdfi, MyHC I, MyHC IIa and MyHC IIb of the Laiwu pigs;
FIG. 2 is a graph showing the results of the conversion of myofiber types from glycolytic to oxidative following the myogenic differentiation of C2C12 cells promoted by Mdfi: FIG. A is the MyHC I immunofluorescence results at 7 days of C2C12 overexpression of Mdfi, FIG. B is the MyHC IIa immunofluorescence results at 7 days of C2C12 overexpression of Mdfi, FIG. C is the MyHC IIb immunofluorescence results at 7 days of C2C12 overexpression of Mdfi, and FIG. D is the Tnni1, Tnni2, MyHC I, MyHC IIa, MyHC IIb, MyHC IIx/D and myoglobin (myoglobin, Mb) fluorescence quantification results at 7 days of C2C12 overexpression of Mdfi: wherein N is 3, x: p <0.05, x: p is less than 0.01, the magnification of the picture is 100 times, and the ruler is 100 mu m;
FIG. 3 is a graph showing the result of Western blot detection of MyHC protein expression in the fast and slow muscle fiber type after the overexpression of Mdfi in the hind leg muscle of 8-week-old C57BL/6J mice embedded with adeno-associated virus.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings.
Example 1: mdfi and myofiber type marker protein expression detection in muscle tissue of Laiwu pigs and white pigs
1) Experimental Material
The psoas major muscle from leypus pigs and large white pigs, the longissimus dorsi and psoas major muscle from leypus pigs.
2) Instrumentation and equipment
According to the Western blot experiment steps, the related instruments and equipment are as follows: centrifuge 5804R desk top high speed refrigerated Centrifuge (Eppendorf, germany); iMarkTMMicroplate Reader (U.S. BIO-RAD), ice maker (Japan Sanyo), vertical transfer tank (Shanghai-Tian-Nei), protein electrophoresis apparatus (Shanghai-Nei), Color liquid magnetic stirrer (German IKA), PowerPac (TM) Universal electrophoresis apparatus power supply (U.S. BIO-RAD), VORTE × 4 clingial circumferential oscillator (German IKA), Yipu Yida ultra-pure water system (Sichuan Yopu ultra-pure science and technology Co.), HS-3 vertical mixer (Ningbo New Ganoderma Biotech), D1008E palm centrifuge (U.S. SCILOGEX), transfer decolorizing shaker TS-8 (Yangbei of Jiangsu Haiman, Tubeier), Flor ChemMPolychromatic fluorescence and chemiluminescence imaging systems (Protein Simple, usa); pipette (GILSON, usa).
3) Experiment consumable
According to the Western blot experiment steps, the related consumables are as follows: 5 × Loading Buffer (Shanghai Biyun sky); SDS-PAGE protein loading buffer (Shanghai Biyun day); PMSF (shanghai bi yunnan ST 505); RIPA lysate (strong) (shanghai bi yun tian).
4) Extraction of total protein of Laiwu pig lumbar large muscle tissue
Shearing the psoas major muscle tissue with scissors, adding RIPA lysis buffer (strong), adding protease inhibitor PMSF, mashing the muscle tissue with homogenizer, and splitting on ice for half an hour while shaking the lysis buffer. And finally, centrifuging the mixture for 15 minutes at 12,000g of a desktop high-speed refrigerated centrifuge, taking the supernatant, adding a 5 Xloading Buffer, and carrying out denaturation in water bath at 98 ℃ for 15 minutes to finally obtain total protein for a Western blot experiment in the later period.
5) Western blot detailed procedure
a) Sample preparation: the denatured protein samples were thawed on ice and 30 μ g protein was loaded per well;
b) preparation of 12% separation gel: the preparation is carried out according to the formula: ddH2O2 mL; 0.1mL of 10% SDS; 1.5mol/LTris (pH 8.8)3.8 mL; 0.004mL of TEMED; 0.1mL of 10 percent ammonium persulfate and 4mL of 30 percent acrylamide mixed solution, uniformly mixing the gel, slowly adding the gel into a gel plate, swinging left and right to enable the gel to be horizontal left and right, and then slowly adding ddH into one side of the gel plate2O, sealing the adhesive;
c) preparation of 5% concentrated glue: the preparation is carried out according to the formula: ddH2O6.8 mL; 0.1mL of 10% SDS; 1.5mol/LTris (pH 6.8)1.25 mL; 0.1mL of 10% ammonium persulfate; 1.7mL of 30% acrylamide mixed solution and 0.01mL of TEMED; between the addition of the concentrated glue, the water in the glue plate is sucked dry by using filter paper, then the concentrated glue is slowly added, a cleaned and dried comb is inserted, the comb is slightly pressed downwards, and then glue is supplemented on two sides;
d) electrophoresis: slightly pulling out the comb, then placing the comb in an electrophoresis tank, adding Western blot electrophoresis solution, and then slowly adding protein sample solution; electrophoresis program 80V 40 min; 110V for 1 hour and 30 minutes;
e) film transfer: preparing membrane conversion liquid in advance, adding methanol, sealing with a sealing film to avoid volatilization, and pre-cooling in a refrigerator at 4 ℃; putting a black plate of a film-transferring clamp downwards, sequentially putting a spongy cushion, 3 pieces of thin filter paper, gel, a PVDF film, 3 pieces of thin filter paper and a spongy cushion, clamping, putting the film-transferring clamp in an electrophoresis tank, and transferring the film for 90 minutes at a constant current of 168 mA;
f) and (3) sealing: taking out the PVDF membrane, marking the left upper corner, and distinguishing the sample application sequence and the front side and the back side of the membrane; cutting according to a protein marker, and sealing for 2 hours at room temperature on a shaking bed with 5% skimmed milk powder;
g) incubating the primary antibody: after sealing, washing the strips with TBST, winding the strips into a centrifuge tube, screwing the membrane into the tube with the front side facing inwards, shaking the membrane on a vertical mixer at 4 ℃, and incubating for 12-18 hours;
h) incubation of secondary antibody: washing the strip with TBST for 3-5 times, 3-5 minutes each time; then, according to the property of the primary antibody, performing secondary antibody incubation in a glass dish;
i) color development: washing the strip with TBST for 3-5 times, each time for 3-5 minutes, incubating the strip with a developing solution, and finally performing fluorescence analysis on the strip in a Flour ChemMScanning detection is performed in multicolor fluorescence and chemiluminescence imaging systems. The results are shown in FIG. 1A and FIG. 1B. FIG. 1 shows that the expression level of Mdfi is positively correlated with the expression levels of slow muscle fiber type MyHC I and MyHC IIa in different pig species; in Laiwu pigs, Mdfi and MyHC I and MyHC IIa expression in the psoas major, where there are more slow muscle fibers, are positively correlated.
The primary and secondary antibody information for Western blot is shown in tables 1 and 2 below:
example 2: detection of myofiber type conversion from glycolytic to oxidative after myogenic differentiation of Mdfi promoted C2C12 cells
1) Experimental Material
C2C12 mouse myoblasts were purchased at the ATCC official website under the accession number CRL-1772.
2) Instrumentation and equipment
According to the experimental steps of immunofluorescence and qPCR, the involved instruments and equipment are as follows: CO 22Incubators (Thermo, usa); super clean bench (suzhou jing anta); bench top high speed refrigerated centrifuge (Eppendorf, germany); leicaconfocal laser scanning Microscope SP8 (Lceica, Germany); CFX ConnectTMReal-time System fluorescent quantitative PCR instrument (U.S. BIO-RAD); pipettors (GILSON, usa); NanoDrop One ultramicro nucleic acid protein assay (Thermo, USA).
3) Reagent consumable
According to the experimental steps of immunofluorescence and qPCR, the reagent consumables are as follows: DMEM/HIGH GLUCOSE (HyClone, USA); FBS (Gibco, USA); horse serum (American HyCl)one); ampicillin antibiotic (Shanghai Biyuntian); 5% BSA (doctor Wuhan); triton X-100 (Membrin, Shanghai); trizol (Nanjing Novozan R401-01); DEPC water (shanghai bio-worker); chloroform (Shanghai Biyuntian); isopropanol (shanghai bi yuntian); absolute ethanol (shanghai bi yun tian);IIQ RT Supermix for qPCR (+ gDNA wiper) (Nanjing Novovisan R223); puromycin (GIBCO, usa); construction of Mdfi over-expressed C2C12 cell line to Genome-TALERTM&Genome-CRISPRTM(GeneCopoeia Inc., Rockville, Md., USA); DAPI (shanghai bi yun tian).
4) Screening procedure for Mdfi-overexpressing monoclonal C2C12 cells
According to Genome-TALERTM&Genome-CRISPRTMThe kit comprises the following steps of firstly constructing an Mdfi DONOR vector DONOR-Mdfi: according to the primer Mdfi-F (5 '-3'): ATGTCCCAGGTGAGCGGT, respectively; Mdfi-R (5 '-3'): TCAGGAGGAGAAACAGAGTCC the CDS region of Mdfi (sequence shown in SEQ ID NO: 1) was amplified and cloned into Genome-TALERTM&Genome-CRISPRTMDONOR vector in kit (according to Genome-TALER)TM&Genome-CRISPRTMInstructions for kit to perform the procedure), the DONOR-Mdfi DONOR vector was successfully constructed. According to Invitrogen corporation3000 instructions Co-transfect ROSA vector and DONOR-Mdfi Donor vector in C2C12 cells. After 48 hours, drug screening was performed using 2. mu.g/mL puromycin, followed by screening for Mdfi-expressing monoclonal C2C12 cells according to the clonal loop method. The method comprises the following specific steps:
a) the cells were digested with pancreatin 3 days after drug sieving using 2. mu.g/mL puromycin and then diluted to 1200 cells/cm2The density of (3), inoculating the cells in a 10cm dish, and culturing with a growth type culture medium;
b) observing under a 40-fold microscope, and when one cell is proliferated, the formed cell mass just occupies 40-fold visual field; observing cells under a fluorescence microscope, marking at fixed points, and marking out a single cell mass which emits green light and is formed by proliferation of one cell;
c) soaking cloning rings in 75% alcohol for 5 minutes in a super clean bench, then washing for 3 times by PBS, and finally soaking in PBS for later use;
d) absorbing the culture medium, washing with PBS for 2 times, changing the clone to the place of the marked cell, adding 100 μ L of 0.25% pancreatin, digesting for 2 min at room temperature, and adding 20 μ L of growth type complete culture medium to terminate digestion;
e) gently blowing the cells in the suspension cloning ring, and then directly transferring the cells to a 48-hole cell culture plate;
f) cells adhere to the wall after 12 hours of inoculation, a new complete culture medium is replaced, observation is carried out under a microscope, and fluorescent and non-luminous monoclonal cells are determined and marked;
g) screening in the previous step to obtain monoclonal cells, digesting, obtaining one third of cell suspension after digestion as a sample for homologous recombination identification, transferring the rest to a 24-well plate, and marking at the moment;
h) when the monoclonal cells grow to 80% in a 24-well plate, carrying out digestion passage, namely three to 6-well plates, according to the positive monoclonal cells verified by the PCR in the previous step;
i) when the cells grow to 80%, one hole of cells is used for freezing and storing the cells, one hole of cells is used for extracting RNA, and one hole of cells is used for extracting protein; when the cells were frozen, a small portion was taken for DNA extraction (direct lysis of the cells for PCR identification). And finally, verifying through qPCR, Western blot and homologous recombination PCR, and determining a candidate Mdfi over-expressing monoclonal C2C12 cell line for subsequent experiments.
5) MyHC I/IIa/IIb immunofluorescence experiment procedure
To examine the effect of Mdfi on myofiber type during differentiation of C2C12, myofiber formation was analyzed by MyHC I/IIa/IIb immunofluorescence, respectively, and the detailed assay procedure for 48-well plates was as follows:
a) inoculating wild C2C12 cells and C2C12 cells stably overexpressing Mdfi into a 48-well plate at the same cell density, and performing induced differentiation after the cells are attached to the wall;
b) after induced differentiation for 7 days, the medium was removed and washed twice with 200. mu.L PBS;
c) fixing: add 200. mu.L of 4% paraformaldehyde into each well, shake slowly on a shaker for 30 minutes;
d) washing: the fixative was aspirated off and washed three times with 200 μ L PBS for 20 seconds each;
e) permeabilization: adding 150 mu L of prepared 1% Trition-100 permeabilizing agent into each well, and carrying out permeabilization for 30 minutes on a shaking table;
f) and (3) sealing: removing the permeabilizing agent, washing with PBS 3 times, adding 200 μ L of 5% BSA, and standing at 37 deg.C for 2 hr;
g) incubation of MyHC I antibody: preparing MyHC I antibody diluent with 5% BSA according to the instruction, and incubating at 37 ℃ for 2 hours, wherein each well contains 150 mu LMyHC I antibody diluent; the dilution ratio of the MyHC I antibody is shown in Table 1;
h) washing of MyHC I antibody: MyHC I antibody was recovered and washed three times with 200. mu.L PBS for 5 minutes each; note that the recovered MyHC I antibody may also be subjected to two immunofluorescence assays;
i) incubating a secondary antibody, Goat Anti-Mouse lgG/Cy 3: preparing an antibody diluent by using PBS (phosphate buffer solution), wherein 120 mu L of the secondary antibody diluent is used in each hole, and incubating for 2 hours at room temperature in a dark place; the dilution ratio of the coat Anti-Mouse lgG/Cy3 is shown in Table 2;
j) washing secondary antibody: washed three times with 200 μ L PBS for 5 minutes each;
k) DAPI incubation: DAPI dilutions were prepared according to the instructions, 100 μ L of DAPI dilution was added to each well, incubated for 30 minutes at room temperature, and then subjected to photographic analysis, with three different fields selected for each well. See results fig. 2A.
The effect of Mdfi on MyHC IIa and MyHC IIb type muscle fiber formation was examined using the same method, as shown in fig. 2B and fig. 2C, respectively: the results show that overexpression of Mdfi increases the myotube ratio of MyHC I and MyHC IIa (fig. 2A and 2B), and decreases the myotube ratio of MyHC IIb type (fig. 2C).
6) Fluorescence quantitative determination of mRNA level of fast and slow muscle fiber related gene
To clarify the effect of Mdfi on the mRNA level of the fast and slow muscle fiber-associated genes, respectivelyCells were collected from wild type C2C12 nuclei and from 7 days of differentiation of the C2C12 cell line stably overexpressing Mdfi, subjected to total RNA extraction, and then used by Nanjing NovophiliaII Q RT Supermix for qPCR (+ gDNA wrapper), reverse transcription to obtain cDNA, and final detection using CFX Connect Real-Time System. The primers used are shown in Table 3 below. The results are shown in FIG. 2D: the results show that overexpression of Mdfi extremely significantly increases MyHC I (p)<0.01) and MyHC IIa (p)<0.01) mRNA level, decreased MyHC IIb (p)<0.01) mRNA level. It is demonstrated that overexpression of the Mdfi gene can transform fast to slow muscle fibers and increase the proportion of slow muscle fibers.
Example 3: and (3) overexpressing Mdfi in the hind leg muscle of the mouse by an adeno-associated virus embedding method, separating gastrocnemius muscle, and performing western blot to detect the result of the fast and slow muscle fibers.
1) Experimental Material
C57BL/6J mice (purchased from Guangdong provincial animal center for medical laboratory); adeno-associated virus (AAV; from Kjekay Gene Co., Ltd.) packaging the Mdfi coding region enriches Mdfi in muscle for expression using the MHCK7 promoter.
2) Reagent consumable
A disposable syringe; phosphate Buffered Saline (PBS).
3) Experimental procedure for injecting adeno-associated virus packaging Mdfi coding region into hind leg muscle of C57BL/6J mice
7 weeks old male C57BL/6J common pathogen Free (SPF) grade mice were purchased from the medical laboratory animal center, Guangdong province. The mouse material is of a common SPF grade and meets the national standard. Animal feeding conditions: 1, one plant is cultured per cage; raising temperature and humidity: 20-26 ℃ and 40-70 percent, and adopts 12h day and night intermittent illumination. The condition of the feeding room is always stable, and the feeding room can freely take food and drink water.
② one week after feeding, the mice were injected with the adeno-associated virus containing the Mdfi coding region (SEQ ID NO: 1) at multiple points in the hind leg muscle of C57BL/6J mice using sterile syringes at a virus titer of 1012vg/mL, 10-15 μ L per spot, and 3-5 spots. Normal mice (Wild Type, WT) were injected with an equal volume of PBS. The gastrocnemius muscle of the mouse is a mixed muscle and contains fast muscle fibers and slow muscle fibers. To investigate whether Mdfi has an effect on fast and slow muscle fiber transformation. Thus, one week after injection, the gastrocnemius muscle of the mice was isolated and Western blot examined the protein levels of MyHC associated with fast and slow muscle fiber type. The results are shown in FIG. 3: compared with the WT type group, the over-expression Mdfi (AAV-Mdfi) is shown to reduce the MyHC IIb protein level, increase the MyHC I and MyHC IIa protein levels, and show that the conversion from fast muscle to slow muscle in gastrocnemius of an adult mouse is promoted, and the muscle character of the mouse is improved, so that the over-expression Mdfi is presumed to improve the slow muscle proportion of animals such as pigs or cattle and the like, and further improve the meat quality.
Example 4: a method for improving meat quality in swine by intramuscular injection of an adeno-associated virus containing an Mdfi coding region into the hind leg of the swine.
Weaning piglets with the same genetic background are divided into two groups, namely an experimental group and a control group. The hind leg muscles of the experimental group of piglets were injected with adeno-associated virus containing the Mdfi coding region. The virus titer was 1012vg/mL, 10-15 μ L per spot, and 5-8 spots. Control piglets were injected with an equal volume of PBS. After the pigs of the experimental group and the control group are marked, the pigs are raised to 100 days old under the same condition, and the rear leg muscles of the pigs are detected, and the result shows that the MyHC IIb protein expression of the pigs of the experimental group is reduced, the MyHCI and MyHC IIa protein expression is increased, the muscles are converted from fast muscles to slow muscles, and the pork quality is improved.
Example 5: a method for improving meat quality in swine by injecting an expression plasmid containing an Mdfi coding region into the hind leg muscle of swine.
Weaned piglets with the same genetic background are divided into two groups, namely an experimental group and a control group. The hind leg muscle of the experimental group of piglets was injected with an expression plasmid containing the Mdfi coding region. The plasmid concentration is 20. mu.M, 10-15. mu.L of plasmid is injected into each spot, and 5-8 spots are punched. Control piglets were injected with an equal volume of PBS. After the pigs of the experimental group and the control group are marked, the pigs are raised to 100 days old under the same condition, and the rear leg muscles of the pigs are detected, and the result shows that the MyHC IIb protein expression of the pigs of the experimental group is reduced, the MyHC I and MyHC IIa protein expression is increased, the muscles are converted from fast muscles to slow muscles, and the pork quality is improved.
Example 6: the pork quality is improved by constructing transgenic pigs over-expressing Mdfi.
The DONOR-Mdfi DONOR vector constructed as the method in example 2 is used for transfecting pig fibroblasts, a positive cell line expressing the Mdfi gene is obtained after screening, and the cell line is used as a nuclear DONOR cell of somatic cell cloning to carry out somatic cell cloning, so that the transgenic pig specifically over-expressing the Mdfi gene in the muscle is obtained. The transgenic pig and the negative control group are slaughtered after being raised to 100 days of age under the same feeding condition, the muscle type of the transgenic pig is detected, and the MyHC IIb protein level in the transgenic pig is obviously reduced, the MyHC I and MyHC IIa protein levels are obviously increased, so that the muscle is converted from fast muscle to slow muscle, and the pork quality is improved.
Example 7: the quality of pork is improved by injecting Mdfi gene into fertilized eggs, and then transplanting the fertilized eggs into the uterus of a surrogate pregnant animal to obtain the pig over-expressing the Mdfi gene.
The fertilized eggs of the pig were divided into experimental group and control group. The experimental group was injected with an expression plasmid containing the Mdfi coding region (DONOR-Mdfi DONOR vector constructed as described in example 2) at a plasmid concentration of 20. mu.M and an injection volume of 10 pL. The control group was injected with an equal volume of PBS solution. After the pigs of the experimental group and the control group are marked, the pigs are fed to 100 days of age under the same condition, and the rear leg muscles of the pigs are detected, the results show that the protein levels of MyHC IIb of the pigs of the experimental group are obviously reduced, the protein levels of MyHC I and MyHC IIa are obviously increased, the muscle is converted from fast muscle to slow muscle, and further the quality of the pork is improved.
Sequence listing
<110> southern China university of agriculture
<120> method and application for realizing improvement of animal meat quality through Mdfi gene editing
<130>2020.6.30
<160>1
<170>SIPOSequenceListing 1.0
<210>1
<211>741
<212>DNA
<213> Artificial sequence ()
<400>1
atgtcccagg tgagcggtca gtgcccttct cgctgcgacg cgcctcatgg agtccccagc 60
gctgccctgg acccagccca gaccatgtcc ctcctccctg ggctggaggt agcaagatcc 120
actcaccctg tagaggcatc ttctgaagag ggcttcccgg aggaggcggc accctccatg 180
ccccatgaca gtggtctccg ggctcagcag gctctgaaca gcattgacct cgatgtcccc 240
acagaagctg tgacgtgcca gcctcaaggg aacccccaag gctgcacccc actactgcca 300
aatggctcca gccacgacca cctctcagaa ccgggcagtg cagggcatgc ggggaacggt 360
gctctgggcg ggtccaaggc ccaccggaag ttgcagacgc atccatctct gggcagccag 420
gctggaagga aaagcagagg cagcgcccgg tcagcctcac aggtccctct ccaggcacag 480
gaagattgct gcgtccactg catactgtcc tgtctattct gtgagttcct gacgctctgt 540
aacatcctcc tggactgcgc cacctgtggc tcctgcagct ctgaggactc ctgcctctgc 600
tgctgctgct gtgggtccgg cgagtgcgcg gactgtgacc tgccctgcga cctggactgc 660
ggcatcgtgg atgcctgctg cgagtccgca gactgcttgg agatatgcat ggagtgctgt 720
ggactctgtt tctcctcctg a 741
Claims (10)
1. A method for achieving improved meat quality in an animal by Mdfi gene editing, wherein the method comprises overexpressing the Mdfi gene.
2. The method for improving the quality of animal meat by Mdfi gene editing of claim 1, wherein the method comprises injecting Mdfi in the animal muscle.
3. The method for improving the meat quality of an animal by Mdfi gene editing according to claim 2, wherein the method comprises injecting the animal intramuscularly with an adeno-associated virus containing the Mdfi coding region.
4. The method for improving the meat quality of animals by Mdfi gene editing as claimed in claim 3, wherein the method comprises injecting the animal intramuscular with adeno-associated virus containing Mdfi coding region with a virus titer of 1012vg/mL, 10-15. mu.L per spot.
5. The method for improving the quality of animal meat by Mdfi gene editing of claim 2, wherein the method comprises injecting the expression plasmid containing the Mdfi coding region into the muscle of the animal.
6. The method for improving the meat quality of an animal by Mdfi gene editing according to claim 1, wherein the method comprises obtaining a transgenic animal that overexpresses the Mdfi gene.
7. The method for improving the meat quality of an animal by Mdfi gene editing according to claim 1, wherein the method comprises obtaining an animal over-expressing the Mdfi gene by injecting the Mdfi gene into a fertilized egg and then transplanting the fertilized egg into the uterus of a surrogate pregnant animal.
8. The edited Mdfi gene is applied to the improvement of the quality of animal meat.
9. The use of claim 8, wherein editing the Mdfi gene comprises overexpressing the Mdfi gene in the animal.
10. The use of claim 9, wherein said overexpressing an Mdfi gene comprises at least one of injecting an expression plasmid containing an Mdfi coding region intramuscularly in an animal, injecting an adeno-associated virus containing an Mdfi coding region intramuscularly in an animal, overexpressing a transgenic animal of an Mdfi gene, injecting an Mdfi gene into a fertilized egg and transplanting the Mdfi gene into the uterus of a surrogate pregnant animal to obtain an animal overexpressing an Mdfi gene.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010613570.3A CN111733185A (en) | 2020-06-30 | 2020-06-30 | Method for realizing improvement of animal meat quality through Mdfi gene editing and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010613570.3A CN111733185A (en) | 2020-06-30 | 2020-06-30 | Method for realizing improvement of animal meat quality through Mdfi gene editing and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111733185A true CN111733185A (en) | 2020-10-02 |
Family
ID=72653718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010613570.3A Pending CN111733185A (en) | 2020-06-30 | 2020-06-30 | Method for realizing improvement of animal meat quality through Mdfi gene editing and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111733185A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626652A (en) * | 2003-12-08 | 2005-06-15 | 本元正阳基因技术股份有限公司 | Method for accelerating quick growth of animals and method for improving quality of meat |
CN104388465A (en) * | 2014-09-24 | 2015-03-04 | 华南农业大学 | Application of MDFI in regulation of pig skeletal muscle growth and development |
CN109069672A (en) * | 2016-04-15 | 2018-12-21 | 全国儿童医院研究所 | Gland relevant viral vector transmits micro- dystrophin to treat muscular dystrophy |
-
2020
- 2020-06-30 CN CN202010613570.3A patent/CN111733185A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1626652A (en) * | 2003-12-08 | 2005-06-15 | 本元正阳基因技术股份有限公司 | Method for accelerating quick growth of animals and method for improving quality of meat |
CN104388465A (en) * | 2014-09-24 | 2015-03-04 | 华南农业大学 | Application of MDFI in regulation of pig skeletal muscle growth and development |
CN109069672A (en) * | 2016-04-15 | 2018-12-21 | 全国儿童医院研究所 | Gland relevant viral vector transmits micro- dystrophin to treat muscular dystrophy |
Non-Patent Citations (1)
Title |
---|
焦义仁: "Mdfi对C2C12细胞发育调控及机理探究", 《华南农业大学 博士学位论文》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230272346A1 (en) | Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure | |
Mozdziak et al. | Isolation of chicken primordial germ cells using fluorescence-activated cell sorting | |
CN112410290B (en) | Lateolabrax japonicus myocardial fibroblast line and application thereof | |
CN114621953B (en) | siRNA for specifically inhibiting chicken CTGF gene expression and application thereof | |
CN114480262B (en) | Method for generating functional sperms by 3D in-vitro culture of spermatogonium of Bostrichthys sinensis | |
Chojnacka-Puchta et al. | Obtaining chicken primordial germ cells used for gene transfer: in vitro and in vivo results | |
CN111154763A (en) | Application of long-chain non-coding RNA lncMGPF in regulation and control of pig muscle development function | |
CN105039402B (en) | A kind of method for improveing pig muscle quality | |
Sharma et al. | Successful transplantation of transfected enriched buffalo (Bubalus bubalis) spermatogonial stem cells to homologous recipients | |
CN109536451B (en) | Application of RTL1 gene in regulation and control of myoblast proliferation and differentiation | |
CN111733185A (en) | Method for realizing improvement of animal meat quality through Mdfi gene editing and application | |
CN102807993B (en) | Skeletal muscle specific miRNA expression vector and reconstitution cell of target Myostatin gene | |
CN108465108B (en) | Specific gene target for preventing or treating brain glioma | |
CN111876442B (en) | Preparation method of MC3R gene edited pig fibroblast line | |
US20210310023A1 (en) | Method for preparing fish skin mucous gland bioreactor and application thereof | |
Salabi et al. | Cell culture, sex determination and single cell cloning of ovine transgenic satellite cells in vitro | |
CN110512005B (en) | Application of ubiquitin-specific protease 8 in regulation of Hu sheep meat quality and breeding | |
Chen et al. | Production of transgenic mice expressing the goat H-FABP gene by intratesticular injection | |
CN109576267A (en) | A kind of gRNA, carrier, cell and preparation method thereof for single base editor | |
CN103131722A (en) | Swine gene expression muscle creatine kinase (MCK)-diacylglycerol acyltrabsferase 1(DGAT1) carrier and preparation method thereof | |
CN116411022B (en) | Vector and cell for indicating activation degree of porcine somatic clone embryo genome | |
CN111793606B (en) | Method for improving CRISPR/Cas9-mediated homologous repair efficiency | |
Su et al. | Establishment of Big Bone chicken fibroblast cell bank and study of its biological characteristics. | |
Qu et al. | Protocol for linking enhanced interferon immunity to virus resistance in gene-knockout zebrafish | |
Vu et al. | Cloning Sheep Cytokin Genes and Preliminary Transfect to HT29 Cell Line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201002 |